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Abstract
Background—To date, epidemiological studies have not strongly supported an association 
between pesticide exposure and breast cancer. However, few previous studies had the ability to 
assess specific time periods of exposure. Studies that relied on adult serum levels of metabolites of 
organochlorine pesticides may not accurately reflect exposure during developmental periods. 
Further, exposure assessment often occurred after diagnosis and key tumor characteristics, such as 
hormone receptor status, have rarely been available to evaluate tumor-subtype specific 
associations. We examine the association between pesticide exposure during childhood and 
adolescence and breast cancer risk in the prospective Sister Study cohort (N=50,844 women) to 
assess this relation by tumor subtype.
Methods—During an average 5-year follow-up, 2,134 incident invasive and in situ breast cancer 
diagnoses were identified. Residential and farm exposure to pesticides were self-reported at study 
enrollment during standardized interviews. Multivariable hazard ratios (HR) and 95% confidence 
intervals for breast cancer risk were calculated with Cox proportional hazards regression.
Results—HRs were near null for the association between childhood/adolescent pesticide 
exposure and breast cancer risk overall or among ER+/PR+ invasive tumors. However, among 
women who were ages 0–18 before the ban of DDT in the U.S., exposure to fogger trucks or 
planes was associated with a HR=1.3 for premenopausal breast cancer (95% CI: 0.92, 1.7).
Conclusion—These findings do not support an overall association between childhood and 
adolescent pesticide exposure and breast cancer risk. However, modest increases in breast cancer 
risk were associated with acute events in a subgroup of young women.
Introduction
In 2014, 235,030 new cases of breast cancer were projected to be diagnosed in the U.S., 
making it the most common cancer diagnosis among women. 221 Endogenous and 
exogenous estrogen exposure contribute to breast cancer development; factors such as 
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younger age at menarche and use of postmenopausal estrogen and progestin are recognized 
to increase breast cancer risk.2 Endocrine-disrupting properties have been attributed to 
several environmental agents used for pest control, including the organochlorine 
dichlorodiphenyltrichloroethane (DDT),3–6 suggesting that exposure to pesticides could also 
influence breast cancer risk.
DDT use was widespread in the U.S., with use peaking in 1959, until it was banned in 
1972.7,8 Aerial crop-dusting with DDT was common on farms, and many residential 
communities and beaches were regularly sprayed by municipal fogger trucks.9 Scientific 
reviews addressing the relationship between adult levels of 
dichlorodiphenyldichloroethylene (DDE), the primary metabolite of DDT, and breast cancer 
concluded that the weight of the evidence does not support the association between 
pesticides and breast cancer.8,10–12 However, recent investigations suggest that greater focus 
on vulnerable periods of breast development or acute exposure events is warranted.13
Mammary growth is exponential during the pubertal transition and pregnancy; breast tissue 
may be more susceptible to environmental exposures prior to or during these developmental 
windows.14,15 A nested case-control study found a 5-fold increased risk of breast cancer 
between the 3rd and 1st tertiles of serum p,p’ DDT among women who were ≤14 years old 
when DDT came into use and those who were ≤20 years old during the time of peak DDT 
use.7 Additionally, it has been hypothesized that potential effects of pesticides with 
endocrine-disrupting properties may be specific to breast tumors that express hormone 
receptors. In a case-control analysis of acute pesticide exposure related to fogger trucks, 
White et al. identified an increase in estrogen receptor (ER) positive and progesterone (PR) 
positive breast cancer among women who reported ever seeing a fogger truck before 1972 
(OR: 1.44; 95% CI: 1.08, 1.93)9. These results underscore the need to consider timing of 
exposure and tumor subtype in order to evaluate any potential associations between 
pesticides and breast cancer risk.
The aim of the present study was to assess the relationship between childhood and 
adolescence pesticide exposure and breast cancer in the Sister Study, a prospective cohort of 
50,884 U.S. and Puerto Rican women with a family history of breast cancer.
Methods
This analysis was performed using data from the Sister Study, a prospective observational 
cohort study designed to assess genetic and environmental risk factors for breast cancer and 
other conditions. During 2003–2009, 50,884 U.S. and Puerto Rican women ages 35–74 were 
recruited through the media, breast cancer professionals and advocates, the Internet, a 
network of recruitment volunteers, and a national advertising campaign in English and 
Spanish. Eligible participants had no prior diagnosis of breast cancer at enrollment and had a 
sister who had been diagnosed with breast cancer (http://sisterstudy.niehs.nih.gov/).
All participants provided written informed consent and completed a computer-assisted 
telephone interview that elicited detailed information on medical and family cancer history, 
lifestyle factors, and demographics at enrollment. Participants were asked to complete brief 
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annual health updates and comprehensive follow-up questionnaires every 2–3 years by mail, 
web, or phone to update medical and family histories, lifestyle characteristics and behaviors. 
Response rates were >95% for annual updates and were 94% at the 2 year follow-up 
questionnaire. This research was approved by the Institutional Review Board of the National 
Institute of Environmental Health Sciences, NIH, and the Copernicus Group Institutional 
Review Board.
We excluded records from 128 women who were diagnosed with breast cancer prior to 
completion of study enrollment or had a missing date of diagnosis. Therefore, information 
from 50,756 women contributed to this analysis.
Residential pesticide exposures
All participants were asked to provide a residential history that included the residence they 
lived in for the longest period of time prior to age 14. Details obtained included calendar 
years of residence; whether the property was urban, suburban, small town or rural; if the 
residence was ever used as a farm or orchard; if the residence was treated regularly for pest 
control and if so, how frequently and by whom; and proximity (“within seeing, smelling, or 
hearing distance”) of several land use types including orchards, golf courses, nurseries or 
commercial greenhouses.
Among women who reported ever living on a farm for ≥12 months or that their longest 
residence before age 14 was a farm, additional farm exposure information was collected. 
Living on a farm was defined as a residence where crops are grown or livestock is raised, not 
including small personal gardens. Women were asked to recall characteristics of the farm 
they lived on longest from birth to age 18. Farm characteristics included types of crops or 
livestock, whether pesticides were ever used on the farm, whether participants were ever 
present in fields on the same day as pesticides were applied, whether participants personally 
mixed, loaded, or applied pesticides, cleaned or help clean pesticide mixing or application 
equipment, or ever got an unusually high amount of pesticides on skin or clothing during 
these activities.
Women were also asked to report whether they were ever, “in the fog or spray of chemicals, 
or as a child, did you ever chase after the fogger trucks or airplanes that sprayed for 
mosquitos or other pests?” and, if so, whether this occurred before and/or after 1975. Study 
participants’ ages in 1975 were calculated by subtracting their year of birth. Based on peak 
use of DDT in fogger trucks and planes in 1959, we performed sensitivity analyses to 
examine breast cancer associations specifically among women born in 1941–1958 (who 
would have been ages 0–18 in 1959), and women born during 1944–1949 (who would have 
been pubertal during peak years of DDT use).
Incident breast cancer
Women who reported an incident breast cancer diagnosis during follow-up were asked to 
provide additional diagnostic and treatment details, and to authorize the release of medical 
records. At the time of this analysis, medical records had been obtained for more than 80% 
of incident breast cancers. Agreement was high between self-reported and medical-record 
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abstracted data for estrogen receptor status (95%) and invasiveness (81%) 17. Thus, when 
medical record data were not available, self-reported data were used.
Statistical analysis
Hazard ratios (HR) and 95% confidence intervals (CI) for breast cancer were calculated with 
Cox proportional hazards regression. Statistical models used age as the time scale and 
person-time was accrued from age at study enrollment. Follow-up extended until breast 
cancer diagnosis or the date of last health follow-up. In analyses of breast cancer subtypes 
defined by hormone receptor status and invasiveness, competing or undefined breast cancer 
subtypes were censored at the date of diagnosis. For example, in analysis of ER+PR+ breast 
cancers, women who developed ER- or PR- breast cancers were censored from follow-up 
time at their date of diagnosis. Women were categorized as postmenopausal after 12 months 
of amenorrhea not due to pregnancy, breastfeeding, or premenopausal use of medications 
that induce amenorrhea. Age at menopause was defined as a woman’s age at her last 
menstrual period. Women whose only reason for not experiencing menses was hysterectomy 
(without bilateral oophorectomy) were categorized as postmenopausal after age 55 with 
unknown age at menopause. In analyses investigating associations by menopausal status at 
breast cancer diagnosis, women who reported transitioning from premenopausal to 
postmenopausal during the follow-up period were censored at the month and year for the 
defined age at menopause when considering the outcome of premenopausal breast cancer. 
Person-time after menopausal age contributed to postmenopausal person-time at risk.
Potential confounders were determined a priori; final models adjusted for the following 
covariates: age at menarche (continuous), race (non-Hispanic White, non-Hispanic Black, 
Hispanic, other) and parity/breastfeeding history (nulliparous, parous/never breastfed, 
parous/breastfed). Age at menarche could be considered a potential mediator of the 
association between childhood pesticide exposure and breast cancer risk if women who were 
exposed to pesticides entered menarche earlier.18 Greater duration of breastfeeding could 
have reduced pesticide body burdens in the years between childhood/adolescence and breast 
cancer diagnosis.19 Thus, sensitivity analyses were performed to evaluate the impact of 
statistical adjustment for these covariates. We further evaluated the sensitivity our results in 
statistical models restricted to rural residents and adjusted for age at first birth. All analyses 
were performed using SAS version 9.3 software (SAS Institute, Inc., Cary, NC).
Results
During 270,886 person years of follow-up (mean=5.3 years), 2,134 incident breast cancer 
diagnoses were reported. The majority of diagnoses were invasive breast cancers (n=1,543), 
followed by in situ (n=570) and those of unknown stage (n=21). The mean age at enrollment 
was 56.8 years for cases and 55.1 for non-cases, while mean age at menarche was the same 
(12.6 years) in both groups. Table 1 displays the distribution of person-years according to 
participant characteristics at enrollment. Women who developed breast cancer during 
follow-up were more likely to have been born in the earliest birth cohort, to have ever used 
postmenopausal hormones, and were slightly more likely to have a body mass index > 25 
kg/m2. The average length of time spent at the longest childhood residence was 10.8 years 
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before age 14 and 13.3 years before age 18. Although a minority of women (≤28%) lived at 
a single residence for their entire childhood/adolescence, the majority (≥76%) spent at least 
half their time from ages 0–14 or 0–18 at this residence (data not shown).
We report near null associations between residential exposure to pesticides before age 14 
and breast cancer risk, both overall and specific to ER+/PR+ invasive breast cancer. We 
evaluated residential type, use of a residence as a farm or orchard, and proximity to facilities 
that often use pesticides (orchards, commercial nurseries, golf courses). Roughly 20% 
(N=424) of women who developed breast cancer reported their childhood residence was 
regularly treated with insecticides or pesticides, but few (N=44) reported personally 
applying pest control chemicals (Table 2).
Approximately 20% (N=409) of women who developed breast cancer reported living on a 
farm for ≥12 months before age 18. Compared to women who did not live on a farm, living 
on a farm with livestock, field or orchard crops, working in the fields, and pesticide use on 
the farm were not related to breast cancer risk. The HR for living on a cotton or tobacco 
farm, compared to not living on a farm, was consistent with a higher risk for total breast 
cancer (HR=1.3; 95% CI: 1.0, 1.6), but no association was observed for other cash crops 
(HR=1.0; 95% CI: 0.84, 1.3). Compared to women who lived on farms that did not use 
pesticides, living on a farm that did use pesticides initially appeared inversely associated 
with breast cancer risk (HR=0.80; 95% CI: 0.63, 1.0 for total breast cancer, HR=0.64; 95% 
CI: 0.46, 0.90 for ER+/PR+ invasive breast cancer). However, the direction of the 
association was inconsistent and near null across indicators of personal exposure to 
pesticides such as personally mixing, loading, applying, cleaning equipment or being present 
in fields when pesticides were applied to crops. The HR for breast cancer associated with an 
unusually high amount of pesticides on skin or clothing was suggestive of increased risk 
(HR=1.4; 95% CI: 0.75, 2.5 for total breast cancer; HR=1.5; 95% CI: 0.80, 3.0 for 
postmenopausal breast cancer); however, ≤12 cases reported episodes of high direct contact 
and the confidence intervals were imprecise (Table 3).
We observed no overall association between exposure to fogger trucks or pesticide spray 
from airplanes and breast cancer risk (HR=1.0; 95% CI: 0.93, 1.2) and no variation 
according to whether the exposure occurred before or after 1975 (Table 4). In subgroup 
analyses of women who were exposed to fog or spray and born 1941–1958, those who 
would have been ages 0–18 during years of peak DDT use in the U.S., we observed a 
modest increase in risk of total breast cancer (HR=1.1; 95% CI: 0.99, 1.3) that appeared to 
be driven by cancers diagnosed before menopause (HR=1.3; 95% CI 0.92, 1.7) (Table 4). In 
an analysis restricted to women born in 1944–1949 (who would have been pubertal at time 
of peak DDT use), point estimates were approximately the same, but with wider intervals. 
There were too few cases to evaluate premenopausal breast cancer specifically among 
women born during 1944–1949.
Sensitivity analyses considering the associations between childhood and adolescent pesticide 
exposure restricted to women who were of a normal body mass index at enrollment and 
women who never used postmenopausal hormones did not result in more pronounced 
estimates. Additional sensitivity analyses considering other hormone receptor tumor subtype 
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definitions (ER+ only, ER+ and/or PR+) did not markedly differ from results shown with ER
+PR+ tumors. Similarly, analyses of rural residents only did not differ substantially 
compared to the results shown for all women. Finally, results were virtually unchanged after 
statistical adjustment for age at first birth.
Discussion
Although breast cancer risk was not related to a majority of the pesticide exposures 
examined in this population, there were a few subgroups in which there was a suggested 
increase in risk. These associations were restricted to women having episode(s) with high 
amounts of pesticides on their skin or clothing, those directly exposed to fog or spray, or 
those who would have experienced organochlorine pesticide exposure during puberty. A 
slight association was also found in women who reported living on a cotton or tobacco farm, 
compared to not living on a farm. During the 1960’s and 1970’s, most of the agricultural 
DDT used in the United States was applied to cotton, peanut, and soybean crops.20 Atrazine, 
an herbicide linked to mammary tumors in rats21, was often commonly applied to cotton 
crops during this time period.20 Therefore, the suggested increase in breast cancer risk that 
we observed is biologically plausible.
However, the generally null results found in this paper are consistent with a majority of the 
previously published literature that relied on self-reported exposure pesticides for breast 
cancer risk.22–24 Another recent case-control study using a self-reported measure of acute 
exposure to fogger trucks prior to ages 14 and 20 did not find an increased risk of breast 
cancer.9 Similarly, a population-based case-control study in North Carolina with self-
reported measures of pesticide exposures reported no overall association between farming 
during ages 9–16 years old and breast cancer20 and growing up on a farm was not related to 
breast cancer risk in the study.23 Our study adds new information to the current literature by 
considering both age of exposure and calendar year. The consistency of our findings with 
prior results lends weight to the evidence that pesticide use is not a strong risk factor for 
breast cancer development overall, although specific subgroups may be more vulnerable.
Few studies have evaluated pesticide exposure during adolescence, which may be a critical 
biologic window when breast tissue is more susceptible to carcinogens or exogenous 
estrogens.14,25,26 Organochlorines can act as environmental estrogens and exposure during 
biologically susceptible windows may be most relevant to future breast cancer risk.3–6 For 
example, a study with blood samples collected from 1959–1967 found that high levels of 
p,p’-DDT serum were associated with a 5-fold increase in risk of breast cancer between the 
3rd and 1st tertiles of serum p,p’DDT level among premenopausal women who were born 
during 1931–1944.7 Based on the age-distribution in our study, we could not attempt to 
replicate this finding because there were no premenopausal cancers among women born in 
1931–1944. Nonetheless, our study was able to evaluate a critical time window by assessing 
exposures that occurred at their longest residence from ages 0–14. The average length of 
time that individuals lived at this residence was 10.8 years, likely reflecting exposures across 
childhood and adolescence.
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Current serum levels of pesticides were analyzed as markers of previous exposure in 
multiple previous studies.8 However, current body burden may not reflect relative exposure 
during vulnerable periods of breast development or acute exposures that occurred when 
specific pesticides were ubiquitously used. Body burdens of pesticides may vary due to 
differences in metabolism, body fat, and lactation 27 and residual intake from food sources. 
Studies with archived biological samples that were collected in the relevant time period or 
with adequate sample size to investigate this relationship, are rare.7,28
This study did not identify systematic variation in breast cancer risk when considering only 
ER+PR+ breast cancer. It is hypothesized that breast cancer risk factors may differ by 
hormone receptor status of the tumor, with recent evidence suggesting that traditional 
estrogen-related breast cancer risk factors are more strongly associated with hormone 
receptor positive tumors.29 There have been few studies investigating the association 
between pesticides and breast cancer risk by hormone receptor status. One study suggested 
that ER+ case patients had higher DDE concentrations compared to controls30 and a recent 
Environmental Protection Agency (EPA) report found that ER+ breast cancer was positively 
associated with proportion of agricultural land by county of residence.31 Consistent with 
this, ever seeing a fogger truck at a residence prior to 1972 was associated with a higher 
odds of ER+PR+ tumors in the Long Island Breast Cancer Study Project (OR: 1.44; 95% CI: 
1.08, 1.93).9 However two other studies reported no difference in DDT concentration by 
hormone receptor status32,33 and one report found varying associations between different 
organochlorine compounds and hormone receptor status.34 Inconsistent results among 
hormone receptor subtypes may be due to variation across specific organochlorine 
compounds and lack of statistical power to investigate across multiple tumor subtypes.
Limitations of our analysis should be considered in the interpretation of our results. Multiple 
comparisons were performed so we cannot exclude the possibility that the few elevated 
effect estimates were due to chance. However, the few positive associations were related to 
acute exposure events and may represent a biologically plausible subgroup of exposures. We 
also relied on self-report of childhood and adolescent exposure to pesticides. If women were 
unable to accurately report pesticide exposure during this time period, this could result in 
exposure misclassification. For our binary exposure variables, the direction of bias produced 
by this nondifferential misclassification would be towards the null. For exposures with three 
or more exposure categories the direction of bias from nondifferential misclassification 
could be either toward or away from the null. However, in the highest dose category the bias 
is expected to be towards the null, assuming a monotonic dose-response.35,36 Therefore, 
misclassification of our binary exposure variables or in the highest dose categories could 
result in an attenuated estimate of any true association.
Multiple studies have been carried out to assess the reproducibility of self-reported pesticide 
use in diverse populations.37‒42 These studies compared pesticide exposure reporting 
between repeat questionnaires given 1–2 years apart or, in one study39, 21 years after the 
original assessment. Across studies, the kappa for pesticide-specific questions ranged from 
0.5 and 0.9.37‒39 Three studies reported percent exact agreement from 70% to 94%40–42 for 
general application practices, although it was slightly lower when the question asked about 
specific types of pesticides.40 The authors in each study concluded that there was moderate 
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to high reproducibility for self-reported pesticide exposure and that the level is adequate for 
use in epidemiologic studies. High reliability of self-reported pesticide exposures does not 
exclude the possibility of repeated errors across multiple reports; however, it provides 
reassurance regarding the stability of recall over time.
Although we were unable to validate women’s recall of pesticide exposure directly, we 
asked about 1,000 participants’ mothers some of the same questions answered by their 
daughters to assess their agreement. In a preliminary analysis, we used the mother’s recall of 
their daughter’s pesticide exposure as the gold standard and assumed adult memories would 
be more accurate than childhood memories. Overall agreement was 94% for residence ever 
used as a farm or orchard, and the positive predictive value of the rarer "yes" response was 
76%. The positive predictive value was greater than 90% for pesticides applied to crops on 
the farm. Overall agreement was 75% for longest childhood residence treated regularly with 
insecticides or pesticides but the PPV of a yes response was much lower (56%) (A. 
D’Aloisio, personal communication). Therefore, we are confident of the high data quality 
for our farm-related pesticide exposures, but cannot exclude the possibility of greater relative 
misclassification in residential exposures. The high level of agreement for pesticide 
exposures in other studies, our preliminary validation compared to mothers’ reports, and the 
high stability of childhood residence lend confidence to our self-reported exposure 
measurements.
In the present study, women could have been exposed to a variety of pesticides depending on 
regional agricultural practices, but we did not examine individual pesticides. As previously 
discussed, we did not have blood measurements of organochlorine concentrations. However, 
blood samples at enrollment would not have been an informative exposure assessment due to 
lack of timing of sample collection to relevant etiologic windows and individual variations in 
metabolism. Finally, the women in the Sister Study cohort have a family history of breast 
cancer and thus have a two-fold higher risk of developing breast cancer themselves 
compared to women without a family history of breast cancer. However, the distribution of 
breast cancer risk factors in this study population was similar to that of the general 
population and thus suggests that results from this study may be more broadly 
generalizable.44
Despite these limitations, our study had several strengths; most notably, the self-reported 
pesticide exposure history was obtained prior to diagnosis, which was a unique design of our 
study compared to most previous studies. This is particularly relevant in case-control 
studies; a case-control study conducted in Cape Cod, Massachusetts found that the 
association between cleaning products and breast cancer risk was strongest among those 
who reported the belief that pollutants contributed ‘a lot’ to breast cancer risk.22 Therefore, 
the prospective design used in our study provides assurance that it would not be susceptible 
to differential reporting errors. Additionally, we were able to investigate several measures of 
childhood and adolescent pesticide exposure with more extensive detail than any previous 
study to date. As noted previously, biological samples which have most often measured body 
burdens in later adulthood would not have appropriately addressed our study hypothesis 
about childhood and adolescent exposures due to concerns about degradation. Finally, it was 
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a strength of our analysis that we were able to consider hormone receptor subtype and 
menopausal status at diagnosis as distinct etiologic subgroups.
Overall, the results of this study do not support a strong association between pesticide 
exposure during childhood/adolescence and breast cancer risk as many of the associations 
were near null. Although there were a few modestly elevated breast cancer risk estimates, 
these were associated with acute exposure events and limited by small sample sizes. As 
many of the women who were exposed to organochlorine pesticides in adolescence are now 
coming to an age of highest risk for breast cancer, understanding the long-term impact of 
pesticide exposure during potentially vulnerable periods of breast development remains an 
important research area.
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Table 1
Distribution of Person-Years Contributed by Sister Study Participants According to Breast Cancer Diagnosis 
and Select Characteristics, Sister Study
Cases (N)
N=2,134
Person-Years (PY)
PY=270,886 Distribution of Person Years (% PY)
Birth cohort Cases Non-cases
1928–1946 778 79,389 35.9 29.1
1946–1955 809 107,160 39.1 39.6
1956–1965 491 70,715 22.4 26.2
1966–1974 56 13,622 2.6 5.1
BMI
<18.5 19 3,114 0.8 1.2
18.5–24.9 761 103,339 36.2 38.2
25.0–29.9 685 85,650 32.6 31.6
≥30.0 669 78,688 30.4 29.0
Race
Non-Hispanic White 1,850 232,444 88.5 85.7
Non-Hispanic Black 153 20,636 6.1 7.7
Hispanic 66 10,810 2.2 4.0
Other/unknown 64 6,929 3.2 2.5
Parity/breastfeeding
Nulliparous 397 4,9752 18.5 18.4
Parous, never breastfed 547 6,6029 25.2 24.4
Parous, breastfed 1,190 154,920 56.3 57.2
Unknown 0 185 0.0 0.1
Menopausal hormone therapy
Never 1,153 154,130 55.0 56.9
Estrogen (E) only 409 53,668 18.2 19.9
Estrogen and Progestin (E+P) only 462 51,538 21.6 19.0
E and E+P 106 10,816 5.0 4.0
Unknown 4 733 0.2 0.3
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